JP2010530362A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010530362A5 JP2010530362A5 JP2010510239A JP2010510239A JP2010530362A5 JP 2010530362 A5 JP2010530362 A5 JP 2010530362A5 JP 2010510239 A JP2010510239 A JP 2010510239A JP 2010510239 A JP2010510239 A JP 2010510239A JP 2010530362 A5 JP2010530362 A5 JP 2010530362A5
- Authority
- JP
- Japan
- Prior art keywords
- hpv
- amino acid
- derived
- protein
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94107007P | 2007-05-31 | 2007-05-31 | |
| EP07109287 | 2007-05-31 | ||
| PCT/NL2008/050315 WO2009002159A2 (en) | 2007-05-31 | 2008-05-27 | Intradermal hpv peptide vaccination |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014133168A Division JP5888823B2 (ja) | 2007-05-31 | 2014-06-27 | 皮内ｈｐｖペプチドワクチン接種 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010530362A JP2010530362A (ja) | 2010-09-09 |
| JP2010530362A5 true JP2010530362A5 (enExample) | 2011-06-30 |
Family
ID=38477016
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510239A Pending JP2010530362A (ja) | 2007-05-31 | 2008-05-27 | 皮内ｈｐｖペプチドワクチン接種 |
| JP2014133168A Expired - Fee Related JP5888823B2 (ja) | 2007-05-31 | 2014-06-27 | 皮内ｈｐｖペプチドワクチン接種 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014133168A Expired - Fee Related JP5888823B2 (ja) | 2007-05-31 | 2014-06-27 | 皮内ｈｐｖペプチドワクチン接種 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9562075B2 (enExample) |
| EP (1) | EP2155240B1 (enExample) |
| JP (2) | JP2010530362A (enExample) |
| CN (1) | CN101795705A (enExample) |
| AU (1) | AU2008269721B2 (enExample) |
| BR (1) | BRPI0812311A8 (enExample) |
| CA (1) | CA2688589A1 (enExample) |
| ES (1) | ES2482192T3 (enExample) |
| MX (1) | MX2009012922A (enExample) |
| WO (1) | WO2009002159A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2468763B1 (en) * | 2007-05-31 | 2014-06-18 | Academisch Ziekenhuis Leiden h.o.d.n. LUMC | HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines |
| EP2344191A4 (en) * | 2008-09-02 | 2013-02-13 | Antigen Express Inc | HUMAN PAPILLOMAVIRUS / LI-KEY HYBRIDS AND METHODS OF USE |
| EP2646459B1 (en) | 2010-12-02 | 2020-01-08 | Bionor Immuno AS | Peptide scaffold design |
| EP2883550A1 (en) * | 2013-12-12 | 2015-06-17 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Novel promiscuous HPV16-derived T helper epitopes for immunotherapy |
| CN108289913A (zh) | 2015-10-30 | 2018-07-17 | 儿童国家医疗中心 | 从未致敏t细胞群体产生hpv抗原特异性t细胞 |
| WO2017083963A1 (en) | 2015-11-18 | 2017-05-26 | Immunovaccine Technologies Inc. | Adjuvanting systems and water-free vaccine compositions comprising a polyi:c polynucleotide adjuvant and a lipid-based adjuvant |
| SG11201811442UA (en) * | 2016-06-20 | 2019-01-30 | Isa Pharmaceuticals B V | Formulation of a peptide vaccine |
| US11524063B2 (en) * | 2017-11-15 | 2022-12-13 | Arizona Board Of Regents On Behalf Of Arizona State University | Materials and methods relating to immunogenic epitopes from human papillomavirus |
| AU2019234549B2 (en) | 2018-03-12 | 2026-02-12 | Sqz Biotechnologies Company | Methods for treating HPV-associated diseases |
| US20240374654A2 (en) * | 2018-03-12 | 2024-11-14 | Stemcell Technologies Canada Inc. | Intracellular delivery of biomolecules to modify immune response |
| MA52363A (fr) * | 2018-04-26 | 2021-03-03 | Agenus Inc | Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation |
| EP4271407A1 (en) * | 2020-12-29 | 2023-11-08 | SQZ Biotechnologies Company | Formulations of activating antigen carriers |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
| US5180806A (en) * | 1988-05-16 | 1993-01-19 | The Scripps Research Institute | Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods |
| US5932412A (en) | 1990-05-11 | 1999-08-03 | Euro-Diagnostica Ab | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
| DE9106105U1 (de) * | 1991-05-17 | 1991-11-07 | Behringwerke Ag, 3550 Marburg | Diagnose-Kit zum Nachweis von Human-Papillomavirusinfektionen |
| US6419931B1 (en) | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
| GB9505784D0 (en) * | 1995-03-22 | 1995-05-10 | Lynxvale Ltd | Anti-tumour treatment |
| AU721927B2 (en) | 1995-12-22 | 2000-07-20 | Immunomedics Inc. | Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| ATE304375T1 (de) | 1998-05-23 | 2005-09-15 | Univ Leiden Medical Ct | Cd40 bindende antikörper und ctl peptide zur behandlung von tumoren |
| US20030118588A1 (en) | 1999-05-22 | 2003-06-26 | Linda Diehl | Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40 |
| US6641994B2 (en) * | 1999-08-25 | 2003-11-04 | Pharmacia & Upjohn Company | Methods of identifying anti-viral agents |
| US20020044948A1 (en) * | 2000-03-15 | 2002-04-18 | Samir Khleif | Methods and compositions for co-stimulation of immunological responses to peptide antigens |
| AU2002219711B8 (en) | 2000-12-08 | 2006-03-02 | Academisch Ziekenhuis Leiden | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| EP1417353A4 (en) * | 2001-07-20 | 2005-08-03 | Univ Texas | METHODS AND COMPOSITIONS ASSOCIATED WITH HPV ASSOCIATED PENCILS AND CANNULAR WELLS, INCLUDING CIN |
| US6884605B2 (en) * | 2001-08-09 | 2005-04-26 | Board Of Trustees Of The University Of Arkansas | Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer |
| WO2005063286A1 (en) | 2003-12-23 | 2005-07-14 | Arbor Vita Corporation | Antibodies for oncogenic strains of hpv and methods of their use |
| AU2003290460A1 (en) * | 2003-12-24 | 2005-07-14 | Leiden University Medical Center | Synthetic protein as tumor-specific vaccine |
| US8252893B2 (en) | 2005-01-31 | 2012-08-28 | Board Of Trustees Of The University Of Arkansas | CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof |
| CA2609927A1 (en) * | 2005-04-27 | 2006-11-02 | Leiden University Medical Center | Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
-
2008
- 2008-05-27 MX MX2009012922A patent/MX2009012922A/es active IP Right Grant
- 2008-05-27 EP EP08753797.3A patent/EP2155240B1/en not_active Not-in-force
- 2008-05-27 AU AU2008269721A patent/AU2008269721B2/en not_active Ceased
- 2008-05-27 JP JP2010510239A patent/JP2010530362A/ja active Pending
- 2008-05-27 ES ES08753797.3T patent/ES2482192T3/es active Active
- 2008-05-27 CN CN200880101172A patent/CN101795705A/zh active Pending
- 2008-05-27 CA CA002688589A patent/CA2688589A1/en not_active Abandoned
- 2008-05-27 WO PCT/NL2008/050315 patent/WO2009002159A2/en not_active Ceased
- 2008-05-27 BR BRPI0812311A patent/BRPI0812311A8/pt not_active IP Right Cessation
- 2008-05-27 US US12/451,983 patent/US9562075B2/en not_active Expired - Fee Related
-
2014
- 2014-06-27 JP JP2014133168A patent/JP5888823B2/ja not_active Expired - Fee Related
-
2016
- 2016-12-16 US US15/381,367 patent/US20170143818A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010530362A5 (enExample) | ||
| Wu et al. | Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation | |
| Meyer et al. | Clinical investigations of Toll-like receptor agonists | |
| Lin et al. | Therapeutic hpv DNA vaccines | |
| CN101528255A (zh) | Hpv抗原融合蛋白疫苗组合物及其应用 | |
| JP6811014B2 (ja) | Ｂ型肝炎ウイルスに対するワクチン | |
| Zhang et al. | Effects of astragalus polysaccharide on the immune response to foot-and-mouth disease vaccine in mice | |
| CN1678344A (zh) | 人乳头状瘤病毒治疗 | |
| WO2003090686A3 (en) | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality | |
| JP2013542224A5 (enExample) | ||
| JP2009541373A5 (enExample) | ||
| JP2026063187A (ja) | Ｉ型インターフェロン遺伝子を刺激するための方法及びカチオン性脂質を含む組成物 | |
| RU2011123700A (ru) | Нонапептид с противоопухолевой активностью | |
| US20190002505A1 (en) | Novel peptide and use thereof | |
| JP2014508734A5 (enExample) | ||
| JP2021516991A5 (enExample) | ||
| JP2022172244A5 (enExample) | ||
| JP2010506926A5 (enExample) | ||
| US8470372B2 (en) | Material with immunogenicity | |
| Peng et al. | Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines | |
| WO2017177908A1 (zh) | Pd-l1和pd-l2重组蛋白及其用途 | |
| KR100904844B1 (ko) | 인유두종 바이러스（ｈｐｖ）유전자를 포함하는자궁경부암의 치료 또는 예방용 ｄｎａ 백신 | |
| CN105732780B (zh) | 一种枯草颖肽素及其应用 | |
| RU2006119462A (ru) | Применение специфических гистонов при лечении паразитарных заболеваний | |
| JP6663438B2 (ja) | 癌および皮膚病変の治療 |